A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis

Clinical trial NCT02064816 · COMPLETED

Trial details

NCT number: NCT02064816
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2014-05-31
Primary completion: 2016-04-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.